Bruker BRKR Bsi Biospin — D&A
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Bruker in its filing.
Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.
The official record: Bruker’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bruker's bsi biospin — d&a.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bruker's bsi biospin — D&A?
- Bruker (BRKR) reported bsi biospin — D&A of $11.7M in Q1 2026.
- How has Bruker's bsi biospin — D&A changed year-over-year?
- Bruker's bsi biospin — D&A increased by 12.5% year-over-year, from $10.4M to $11.7M.
- What is the long-term trend for Bruker's bsi biospin — D&A?
- Over 4 years (2021 to 2025), Bruker's bsi biospin — D&A has grown at a 19.3% compound annual growth rate (CAGR), from $21.3M to $43.2M.
- What does bsi biospin — D&A mean?
- The non-cash cost representing the gradual loss of value of the BioSpin segment's physical and intangible assets.
- How do you interpret bsi biospin — D&A?
- A steady increase often correlates with a larger asset base, while sudden spikes may indicate asset write-downs or changes in accounting estimates.
- How does bsi biospin — D&A compare across companies?
- Standard D&A metric found in cash flow and segment reporting.